Is Angioplasty at Centers Without Surgical Backup Safe?

Performing coronary angioplasties at hospitals without surgical backup seems to be safe for a wide variety of patients, from those presenting ST-segment elevation myocardial infarction to those undergoing elective procedures.

 

This work responds to a long-running debate over whether centers without on-site surgery capabilities in case of complications can be considered as referral centers for primary angioplasty (emergency angioplasty) only, or can also perform scheduled procedures.

 

Centers without surgical capabilities have argued in their defense that the performance of scheduled procedures ensured that proper proficiency be maintained for emergency cases.

 

This is the first real-world study showing that it is probably safe to perform coronary angioplasties at centers without surgical backup.

 

The study included data from the Nationwide Inpatient Sample of almost 7 million patients who received an angioplasty in the United States between 2003 and 2012. Overall, 5.7% of the procedures were performed at centers without surgical backup, and the proportion increased with time (1.8% in 2003 vs. 12.7% in 2013; p < 0.001).

 

Hospitals lacking surgical backup performed primary angioplasties more frequently than larger centers with surgical capabilities (34% vs. 20%; p < 0.001).

  • The rate for non-ST-segment elevation acute coronary syndrome was similar (41.8% vs. 42.6%).
  • Scheduled angioplasties were more frequent at centers with surgical capabilities (24.1% vs. 38.2%).
  • Mortality was lower at centers with on-site surgery (1.4% vs. 1.9%; odds ratio [OR] 0.74), but the difference disappeared after researchers adjusted for procedural indication (elective or emergency procedure).

 

The annual angioplasty volume was less than 200 annual cases in two-thirds of the centers without surgical backup.

 

Original title: Outcomes and Temporal Trends of Inpatient Percutaneous Coronary Intervention at Centers With and Without On-site Cardiac Surgery in the United States.

Presenter:  Goel K.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...